Fresenius confirms the sale of its clinics. The consortium formed by KKR and GED subsequently acquired Eugin Assisted Reproduction Clinics He paid about 500 million euros to FreseniusAlthough the final closure of the operation is subject to usual regulatory approvals. Specifically, GED Capital acquired Eugene’s businesses in Spain, Italy, Sweden, Denmark, Latvia, Portugal, Brazil, Argentina and Colombia. For its part, KKR, through Ivirma, has acquired companies in the United States and Canada.
In this way, the business acquired by GED, with a turnover of approximately one hundred million euros, includes more than 35 clinics, in addition to central services located at the headquarters in Barcelona, where the Eugene Group is managed. In fact, this constitutes an acquisition The seventh operation of the GED VI Fund Spain The third is in the health sector, after investments in the biotechnology company Vitro.
“We are convinced that the acquisition of Eugene Ocean in Europe and Latin America will be a great investment,” emphasized Enrique Centellis Satrostegui, Managing Partner of GED Capital. The director added, “It is an excellent growth platformwith great brand fame and prestige, within a clearly expanding activity such as assisted reproduction.
The business acquired by GED, with a turnover of approximately one hundred million euros, includes more than 35 clinics
The Eugene sale process began during the first quarter of the year, with Appointment of Lazard as financial advisor Of the process. This happened at the request of the Elliott Fund, which entered Fresenius at the end of 2022. However, the sale only affects the Eugene group: other fertility treatments from Quirónsalud’s Fresenius clinics will remain part of the German multinational.
Eugene is distinguished by providing personalized solutions in all areas of assisted reproduction, especially in treatments that require specialized procedures, as well as through His commitment to researchwhich has its own research and development (R&D) team of 25 people.
Likewise, the Eugene team is an active part of national and international fertility reference societies, participates in the most important relevant scientific conferences, and carries out an important mission. Awareness work Through his event, the Epart Conference, and his activity within the framework of the Eugene Pompeu Fabra University Chair.